1 As part of the investigation an exploration of potential strategies that might be implemented to reduce errors was undertaken. JQ1 In line with the Medical Research Council (MRC) framework guidance for
the development and evaluation of complex interventions, the aim of this study was to explore the feasibility of the proposed interventions including what involvement pharmacists may play. Multiple strategies were used to identify participants for the focus group. These included placing adverts, radio announcements and including participants from previous GMC study.1 Nine focus groups consisting Epigenetic signaling pathway inhibitor of health care professionals (HCPs) and two focus groups with members of the public were conducted between October 2012 and January 2013. The 98 participants consisted of 50 general practice staff, 28 pharmacists and 20 members of the public. Four researchers
facilitated the focus groups. The discussions were audio recorded with permission, transcribed verbatim and resulting transcripts analysed qualitatively to identify key themes. An inconvenience allowance was provided to all participants. Where applicable, travel expenses and a light lunch were provided to participants. Ethical approval was obtained for this study. www.selleck.co.jp/products/forskolin.html There was a general consensus that pharmacists were recognised as the experts of medicine and were seen as a ‘safety net’ by virtue of their position in the prescribing and dispensing process. Additionally, their involvement in medication reviews, specialised clinics and repeat prescribing enabled them to identify errors. Their contribution in improving the use of prescribing systems and training within practices was seen to enhance prescribing. HCPs endorsed pharmacists conducting structured reviews with feedback
on a set of a GP’s prescriptions, especially for GP Registrars. There was differing opinion in the suitability of the pharmacy undergraduate training and post-qualification experiences (hospital vs. community) in equipping pharmacists with the right skills and attitude to work alongside GPs and members of the public to make prescribing safer. Both GPs and pharmacists recognised that GPs appeared to be more willing to take ‘risks’ when it came to prescribing, whereas pharmacists’ training resulted in them being more risk averse. This was recognised by both groups as a possible source of tension when they worked together.
No related posts.